Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study

Abstract
No abstract available
Funding Information
  • AbbVie
  • AbbVie Deutschland

This publication has 19 references indexed in Scilit: